Phase 1 safety and immunogenicity testing of DNA and recombinant modified vaccinia Ankara vaccines expressing HIV-1 virus-like particles (Q34772727)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Phase 1 safety and immunogenicity testing of DNA and recombinant modified vaccinia Ankara vaccines expressing HIV-1 virus-like particles |
scientific article |
Statements
1 reference
Phase 1 safety and immunogenicity testing of DNA and recombinant modified vaccinia Ankara vaccines expressing HIV-1 virus-like particles (English)
1 reference
David C Montefiori
1 reference
Bernard Moss
1 reference
Lindsey R Baden
1 reference
Linda S Wyatt
1 reference
Georgia D Tomaras
1 reference
Sharon E Frey
1 reference
Spyros A Kalams
1 reference
Paul A Goepfert
1 reference
Marnie L Elizaga
1 reference
Alicia Sato
1 reference
Li Qin
1 reference
Massimo Cardinali
1 reference
Christine M Hay
1 reference
John Hural
1 reference
Stephen C DeRosa
1 reference
Olivier D DeFawe
1 reference
Yongxian Xu
1 reference
William A Blattner
1 reference
National Institute of Allergy and Infectious Diseases HIV Vaccine Trials Network
1 reference
31 January 2011
1 reference
1 reference
203
1 reference
5
1 reference
610-619
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference